TRAF3IP3 and hepatocellular carcinoma: Additionally, analysis of an external cohort (GSE14520, n = 221) confirmed that increased TRAF3IP3 expression was associated with a favorable prognosis for HCC patients (Fig. 2C, p = 0.011).